Company Filing History:
Years Active: 2018-2022
Title: Marc Salome: Innovator in Pharmaceutical Compositions
Introduction
Marc Salome is a notable inventor based in Mervilla, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize methyl cyclodextrins for health benefits. With a total of two patents to his name, Salome's work focuses on increasing HDL cholesterol levels to treat and prevent various diseases.
Latest Patents
Salome's latest patents revolve around the use of methyl cyclodextrins in pharmaceutical compositions. The first patent describes a composition aimed at treating and preventing diseases by increasing HDL cholesterol levels. This composition includes at least one methyl cyclodextrin with a molar substitution degree ranging from 0.05 to 1.5. The second patent highlights a novel use of a similar pharmaceutical composition, emphasizing its potential in treating atherosclerosis and complications related to atheroma, as well as diseases affecting the central nervous system. These compositions are also noted for their ability to reduce circulating fatty acid and triglyceride levels, thereby preventing atheromatous plaques.
Career Highlights
Throughout his career, Marc Salome has worked with prominent companies in the pharmaceutical industry, including Roquette Frères. His expertise in the field has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Salome has collaborated with notable professionals in his field, including Daniel Wils and Xavier Parissaux. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Marc Salome's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His work with methyl cyclodextrins showcases the potential for new treatments in managing cholesterol levels and related diseases.